<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hendy DA</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NIAID NIH HHS</funding><pagination>4687-4697</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11654055</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(9)</volume><pubmed_abstract>Current seasonal influenza vaccines are limited in that they need to be reformulated every year in order to account for the constant mutation of the virus. Hemagglutinin (HA) immunogens have been developed using a computationally optimized broadly reactive antigen (COBRA) methodology, which are able to elicit an antibody response that neutralizes antigenically distinct influenza strains; however, subunit proteins are not immunogenic enough on their own to generate a substantial immune response. Due to this, different delivery strategies and adjuvants can be used to improve immunogenicity. Recently, we reported a new coordination polymer composed of the dipeptide carnosine and zinc (ZnCar) that is able to deliver protein antigens along with CpG to generate a potent immune response. In the p</pubmed_abstract><journal>Molecular pharmaceutics</journal><pubmed_title>Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability.</pubmed_title><pmcid>PMC11654055</pmcid><funding_grant_id>NIH R01AI147497</funding_grant_id><funding_grant_id>75N93019C00052</funding_grant_id><funding_grant_id>R01 AI147497</funding_grant_id><pubmed_authors>Hendy DA</pubmed_authors><pubmed_authors>Ainslie KM</pubmed_authors><pubmed_authors>Mousa JJ</pubmed_authors><pubmed_authors>Bachelder EM</pubmed_authors><pubmed_authors>Lifshits LM</pubmed_authors><pubmed_authors>Batty CJ</pubmed_authors><pubmed_authors>Carlock MA</pubmed_authors><pubmed_authors>Ross TM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Zinc Carnosine Metal-Organic Coordination Polymer as a Potent Broadly Active Influenza Vaccine Platform with In Vitro Shelf-Stability.</name><description>Current seasonal influenza vaccines are limited in that they need to be reformulated every year in order to account for the constant mutation of the virus. Hemagglutinin (HA) immunogens have been developed using a computationally optimized broadly reactive antigen (COBRA) methodology, which are able to elicit an antibody response that neutralizes antigenically distinct influenza strains; however, subunit proteins are not immunogenic enough on their own to generate a substantial immune response. Due to this, different delivery strategies and adjuvants can be used to improve immunogenicity. Recently, we reported a new coordination polymer composed of the dipeptide carnosine and zinc (ZnCar) that is able to deliver protein antigens along with CpG to generate a potent immune response. In the p</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Sep</publication><modification>2025-04-27T00:30:07.267Z</modification><creation>2025-04-06T17:50:50.451Z</creation></dates><accession>S-EPMC11654055</accession><cross_references><pubmed>37603310</pubmed><doi>10.1021/acs.molpharmaceut.3c00424</doi></cross_references></HashMap>